Zobrazeno 1 - 7
of 7
pro vyhledávání: '"JueYu Zhou"'
Autor:
Weiwei Liu, Chaoqun Liu, Hui Wang, Lijun Xu, Jueyu Zhou, Sihua Li, Yu Cheng, Rui Zhou, Liang Zhao
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 5150-5161 (2022)
Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy by restoring the host antitumor immune response. Since 2011, various ICIs have been approved for the treatment of cancers, which has led to unprecedented prolongation of the
Externí odkaz:
https://doaj.org/article/8c412b2c29f14aceb765cb671d7351f1
Publikováno v:
Journal of Cellular and Molecular Medicine
Xanthatin (Xa) is a bicyclic sesquiterpene lactone identified from the plant Xanthium L. with impressive antitumor activity, but the role of Xa in non‐small cell lung cancer (NSCLC) is not known. Here we found that Xa inhibits proliferation, migrat
Autor:
Hui Wang, Rui Zhou, Chuang Lin, Shibin Yang, Liang Zhao, Kunhe Wu, Jueyu Zhou, Lijun Xu, Jian Liu, Shuai Yang, Pingping Yan
Publikováno v:
Oncogene. 39:5743-5755
LIM and SH3 protein 1 (LASP1) is a metastasis-related protein reported to enhance tumour progression in colorectal cancer (CRC). However, the underlying mechanism is still elusive. As the major biological and pathological functions of LASP1 are accom
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 38(7)
OBJECTIVE: To investigate the alterations in gene expression profiles of cervical cancer cell line SiHa over-expressing miR-519d. METHODS: SiHa cells were transfected with a miR-519d mimic or a negative control (NC) and the changes in gene expression
Autor:
Wei Xia1,2 xiawei123456@126.com, JueYu Zhou1, HaiBo Luo2, YunZhou Liu2, CanCan Peng1, WenLing Zheng1, WenLi Ma1 weneli0626@126.com
Publikováno v:
Cancer Cell International. 1/25/2017, Vol. 17, p1-11. 11p.
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 29(10)
To construct the eukaryotic expression vector of short hairpin RNA (shRNA) targeting human collagen type 1 alpha 1 (COL1A1) and observe its inhibiting effect on the expression of target gene.The complementary oligonucleotide sequences coding shRNA we
Publikováno v:
Biomedical Reports; 2014, Vol. 2 Issue 3, p396-403, 8p